home / stock / sngx / sngx news


SNGX News and Press, Soligenix Inc. From 07/28/20

Stock Information

Company Name: Soligenix Inc.
Stock Symbol: SNGX
Market: NASDAQ
Website: soligenix.com

Menu

SNGX SNGX Quote SNGX Short SNGX News SNGX Articles SNGX Message Board
Get SNGX Alerts

News, Short Squeeze, Breakout and More Instantly...

SNGX - Soligenix rallies on encouraging data on COVID-19 vaccine

Nano cap Soligenix (NASDAQ: SNGX ) jumps  46%  premarket on increased volume in reaction to the publication of preclinical data on CiVax, its heat-stable subunit COVID-19 vaccine candidate. More news on: Soligenix, Inc., Healthcare stocks news, Stocks on the move, Read mo...

SNGX - Soligenix Announces Publication of Positive Pre-clinical Results for a Novel COVID-19 Vaccine

PRINCETON, N.J. , July 28, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today publi...

SNGX - Soligenix Issues Corporate Update - Highlights Important Catalysts for Second Half of 2020

PRINCETON, N.J. , July 20, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, today issued an updat...

SNGX - Smaller cap COVID-19 vaccine players under pressure on Pfizer data

Investors are apparently reacting to Pfizer and BioNTech's release of encouraging preliminary early-stage data on COVID-19 vaccine candidate BNT162b1 that showed significant jumps in neutralizing antibodies compared to convalescent plasma. More news on: AstraZeneca PLC, GlaxoSmithKline p...

SNGX - FDA guides on COVID-19 vaccine approval criteria

The FDA has released guidance on its standards for approving a COVID-19 vaccine, including a requirement that it must demonstrate that it is at least 50% more effective than placebo (a low bar compared to vaccines for other infectious diseases). More news on: AstraZeneca PLC, GlaxoSmithK...

SNGX - NKLA, COTY among premarket gainers

BioHiTech Global (NASDAQ: BHTG ) +89%  on potential demand for Altapure disinfectant in COVID-19. More news on: BioHiTech Global, Inc., Kiniksa Pharmaceuticals, Ltd., CleanSpark, Inc., Stocks on the move, , Read more ...

SNGX - Are These Top Penny Stocks To Watch Before Next Week?

Penny Stocks To Watch Before The End Of The Month Are penny stocks on your watch list right now? If not, you may want to at least take a look at a few right now. That is, if you have an appetite for risk. At the end of the day, penny stocks are high-risk/high-reward equities that can realize...

SNGX - INO, DVAX among premarket gainers

MDC Partners (NASDAQ: MDCA ) +169%  on potential business combination with Stagwell. More news on: MDC Partners Inc., Vaxart, Inc., iBio, Inc., Stocks on the move, , Read more ...

SNGX - Bad COVID news, good news for COVID vaccine & drugmakers

The silver lining in the persistence of COVID-19 infections, at least for some investors, is the bullish outlook for companies developing vaccines and/or therapies for the respiratory infection. More news on: Vir Biotechnology, Inc., Dynavax Technologies Corporation, Novavax, Inc., Healthc...

SNGX - Soligenix completes enrollment in late-stage study of dusquetide for oral mucositis

Soligenix (NASDAQ: SNGX ) has hit the enrollment target  of 268 subjects in a Phase 3 clinical trial, DOM-INNATE , evaluating SGX942 (dusquetide) for the treatment of oral mucositis in patients with head and neck cancer, a debilitating inflammatory condition caused by cancer treatment...

Previous 10 Next 10